These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat. Schreiber R; De Vry J Eur J Pharmacol; 1993 Nov; 249(3):341-51. PubMed ID: 7904566 [TBL] [Abstract][Full Text] [Related]
26. Characterisation of the selective 5-HT1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1-[2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): in vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity. Dawson LA; Hughes ZA; Starr KR; Storey JD; Bettelini L; Bacchi F; Arban R; Poffe A; Melotto S; Hagan JJ; Price GW Neuropharmacology; 2006 Jun; 50(8):975-83. PubMed ID: 16581092 [TBL] [Abstract][Full Text] [Related]
27. 5-HT1A receptor agonist properties of the antipsychotic, nemonapride: comparison with bromerguride and clozapine. Assié MB; Cosi C; Koek W Eur J Pharmacol; 1997 Sep; 334(2-3):141-7. PubMed ID: 9369342 [TBL] [Abstract][Full Text] [Related]
28. New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors. Kidd EJ; Haj-Dahmane S; Jolas T; Lanfumey L; Fattaccini CM; Guardiola-Lemaitre B; Gozlan H; Hamon M J Pharmacol Exp Ther; 1993 Feb; 264(2):863-72. PubMed ID: 8094756 [TBL] [Abstract][Full Text] [Related]
29. Biochemical, electrophysiological and neurohormonal studies with B-20991, a selective 5-HT1A receptor agonist. Caicoya AG; Beneytez ME; Delgado M; Manzanares J; López-Rodríguez ML; Benhamu B; Morcillo MJ; Pozo MA; Rubia FJ; Fuentes JA Pharmacology; 2001 May; 62(4):234-42. PubMed ID: 11360001 [TBL] [Abstract][Full Text] [Related]
30. Are postsynaptic 5-HT1A receptors involved in the anxiolytic effects of 5-HT1A receptor agonists and in their inhibitory effects on the firing of serotonergic neurons in the rat? Jolas T; Schreiber R; Laporte AM; Chastanet M; De Vry J; Glaser T; Adrien J; Hamon M J Pharmacol Exp Ther; 1995 Feb; 272(2):920-9. PubMed ID: 7853210 [TBL] [Abstract][Full Text] [Related]
31. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells. Pauwels PJ; Van Gompel P; Leysen JE Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063 [TBL] [Abstract][Full Text] [Related]
32. MP-3022, a new putative antagonist at pre- and postsynaptic 5-HT1A receptors. Przegaliński E; Filip M; Bijak M; Wedzony K; Budziszewska B; Tokarski K; Maćkowiak M; Fijał K Pol J Pharmacol; 1996; 48(1):13-22. PubMed ID: 9112623 [TBL] [Abstract][Full Text] [Related]
33. Involvement of 5-HT1A receptors in the anxiolytic action of S 14671 in the pigeon conflict test. Schreiber R; Brocco M; de Ladonchamps BL; Millan MJ Pharmacol Biochem Behav; 1995; 51(2-3):211-5. PubMed ID: 7667330 [TBL] [Abstract][Full Text] [Related]
34. Discriminative stimulus characteristics of BMY 14802 in the pigeon. Vanecek SA; Essman WD; Taylor DP; Woods JH J Pharmacol Exp Ther; 1998 Jan; 284(1):1-9. PubMed ID: 9435153 [TBL] [Abstract][Full Text] [Related]
35. New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation. Jurczyk S; Kołaczkowski M; Maryniak E; Zajdel P; Pawłowski M; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E; Bojarski AJ; Charakchieva-Minol S; Duszyńska B; Nowak G; Maciag D J Med Chem; 2004 May; 47(10):2659-66. PubMed ID: 15115407 [TBL] [Abstract][Full Text] [Related]
36. Behavioral studies of serotonin receptor agonists as antidepressant drugs. Lucki I J Clin Psychiatry; 1991 Dec; 52 Suppl():24-31. PubMed ID: 1684363 [TBL] [Abstract][Full Text] [Related]
37. Characterization of 5-hydroxytryptamine1A properties of flesinoxan: in vivo electrophysiology and hypothermia study. Hadrava V; Blier P; Dennis T; Ortemann C; de Montigny C Neuropharmacology; 1995 Oct; 34(10):1311-26. PubMed ID: 8570029 [TBL] [Abstract][Full Text] [Related]
38. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists. Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755 [TBL] [Abstract][Full Text] [Related]
39. Behavioral studies with anxiolytic drugs. IV. Serotonergic involvement in the effects of buspirone on punished behavior of pigeons. Witkin JM; Mansbach RS; Barrett JE; Bolger GT; Skolnick P; Weissman B J Pharmacol Exp Ther; 1987 Dec; 243(3):970-7. PubMed ID: 2891840 [TBL] [Abstract][Full Text] [Related]